Molindone: an apomorphine antagonist in the rabbit
Beymer, C.H.; Quock, R.M.
Communications in Psychopharmacology 1(4): 385-392
1977
ISSN/ISBN: 0145-5699 PMID: 615699 Document Number: 113646
Document emailed within 1 workday
Related Documents
Mori, T.; Sugawara, T.; Hosobe, Y.; Gotoh, T.; Kato, C.; Tazawa, Y. 1996: The effect of calcium antagonist on ischemia-reperfusion injury of the rabbit retina Nippon Ganka Gakkai Zasshi 100(10): 773-776Ericsson, H.; Tholander, B.; Björkman, J.A.; Nordlander, M.; Regårdh, C.G. 1999: Pharmacokinetics of new calcium channel antagonist clevidipine in the rat, rabbit, and dog and pharmacokinetic/pharmacodynamic relationship in anesthetized dogs Drug Metabolism and Disposition: the Biological Fate of Chemicals 27(5): 558-564
Hajj-Ali, A.F.; Wong, P.C. 1993: Beta adrenoceptor blockade in rabbit inhibits the renin-releasing effect of AT1 receptor antagonist losartan Journal of Pharmacology and Experimental Therapeutics 267(3): 1423-1427
Montrucchio, G.; Alloatti, G.; Mariano, F.; Tetta, C.; Emanuelli, G.; Camussi, G. 1986: Cardiovascular alterations in the rabbit infused with platelet activating factor (PAF): effect of kadsurenone, a PAF-receptor antagonist International Journal of Tissue Reactions 8(6): 497-504
Honda, K.; Nakagawa, C. 1986: Alpha-1 adrenoceptor antagonist effects of the optical isomers of YM-12617 in rabbit lower urinary tract and prostate Journal of Pharmacology and Experimental Therapeutics 239(2): 512-516
Pandurangi, A.K.; Narasimhachari, N. 1988: Rhabdomyolysis and molindone Journal of Clinical Psychiatry 49(1): 37-38
Cohen, M.L.; Robertson, D.W.; Bloomquist, W.E.; Wilson, H.C. 1992: LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis Journal of Pharmacology and Experimental Therapeutics 261(1): 202-208
Owen, R.R.; Cole, J.O. 1989: Molindone hydrochloride: a review of laboratory and clinical findings Journal of Clinical Psychopharmacology 9(4): 268-276
Kano, T.; Nakamura, S.; Nishi, K. 1988: Effects of a newly synthetized calcium antagonist, cyclopropylmethyl 4-(3-nitrophenyl) 1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylate (MPC-2101), on action potentials of rabbit's myocardial tissues in vitro Archives Internationales de Pharmacodynamie et de Therapie 296: 101-117
Balsara, J.J.; Gada, V.P.; Nandal, N.V.; Chandorkar, A.G. 1984: Psychopharmacological investigation of the monoamine oxidase inhibitory activity of molindone, a dihydroindolone neuroleptic Journal of Pharmacy and Pharmacology 36(9): 608-613
Hwang, S.B.; Lam, M.H.; Hsu, A.H. 1989: Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors Molecular Pharmacology 35(1): 48-58
Meller, E.; Friedman, E. 1982: Differential dose- and time-dependent effects of molindone on dopamine neurons of rat brain: mediation by irreversible inhibition of monoamine oxidase Journal of Pharmacology and Experimental Therapeutics 220(3): 609-615
Ennis, C.; Cox, B. 1980: The dopamine receptor antagonist domperidone is also a competitive antagonist at alpha 1-adrenoceptors Journal of Pharmacy and Pharmacology 32(6): 434-435
Gabay, C.; Porter, B.; Fantuzzi, G.; Arend, W.P. 1998: Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo Journal of Immunology 159(12): 5905-5913
Blettery, B.; Andre, F.; Virot, C.; Escousse, A. 1986: Is apomorphine still usable? Presse Medicale 15(27): 1287
Nagai, A.; Kumon, H. 2002: Clinical evaluation of apomorphine HCl Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 6): 457-460
Giménez-Roldán, S.; García- Muñozguren, S. 2002: Use of apomorphine in Parkinson s disease Revista de Neurologia 35(7): 668-674
Pinder, R.M.; Buxton, D.A.; Woodruff, G.N. 1972: On apomorphine and dopamine receptors Journal of Pharmacy and Pharmacology 24(11): 903-904
Stoliarov, G.V.; Markova, O.F. 1982: Apomorphine in dyskinesia and psychomotor agitation Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 82(8): 97-102
Ziegler, B.; Schneider, E. 1974: Treatment of withdrawal syndrome with apomorphine Arzneimittel-Forschung 24(8): 1117-1119